威高骨科: 山东威高骨科材料股份有限公司关于全资子公司对外投资设立合资公司的公告

Core Viewpoint - The company plans to establish a joint venture, Shandong Weiying Intelligent Medical Technology Co., Ltd., with a registered capital of 50 million RMB, to enhance its capabilities in orthopedic disease diagnosis and planning [1][2][3] Investment Overview - The wholly-owned subsidiary, Weigao Haixing, will invest 24.5 million RMB, accounting for 49% of the joint venture's registered capital [1][2] - The investment aims to optimize resource allocation and improve competitive advantages in the orthopedic industry [2][3] Joint Venture Details - The joint venture will focus on the research, manufacturing, promotion, sales, and after-sales service of weight-bearing cone beam CT imaging products [4][5] - The joint venture's establishment is expected to enhance the company's product sales and brand influence in the orthopedic sector [3][4] Financial and Operational Impact - The investment is made using the company's own funds and is not expected to adversely affect the company's financial status or operational results [13][17] - The joint venture is anticipated to create synergies with existing business operations, enhancing overall competitiveness [13][17] Management and Governance - The joint venture will have a board of directors consisting of five members, with Weigao Haixing nominating two directors [7][11] - The management structure will follow the operational model of Weigao Haixing, ensuring effective governance and compliance [14][15] Strategic Rationale - The establishment of the joint venture aligns with the company's strategic goals to expand its footprint in the orthopedic disease diagnosis and planning market [13][16] - The joint venture is expected to leverage the strengths of all partners involved, facilitating rapid market entry and resource utilization [13][14]